Re: BRD4 inhibition and PARP Inhibition

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Reply New Message

Prev Message Back To Forum Threaded View Next Message

KayakerBC

Rank: Treasurer [?]

Points: 1691 [?]

Votes: 23 Score: 2.6 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

Re: BRD4 inhibition and PARP Inhibition

in response to

Re: BRD4 inhibition and PARP Inhibition

Hartland

posted on Mar 14, 2018 03:53PM

2nd page

"Note: The Company continues to work on securing additional financing as previously disclosed."

3 Recommendations

Reply New Message

Prev Message Back To Forum Threaded View Next Message

Please to post a reply